Unable to load price data. Sorry.

¯\_(ツ)_/¯

Cubist Pharmaceuticals, Inc. (NASDAQ:CBST.DL)

CAPS Rating: No stars

A biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment.

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:CBST.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TerryHoodSr (58.43)
Submitted July 30, 2013

growth

narlinbeaty (< 20)
Submitted May 17, 2008

This company make a drung called Daptomyocin. The drug is affective against MRSA and is used internationally for skin infections and bactermia. In many ways ths drug is a heavy hitting antiboitic used has last line of defense in the hospital setting.… More

NASDAQ:CBST.DL VS S&P 500 (SPY)

NASDAQ:CBST.DL Summary

  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about CBST.DL.

No one has written a Pitch for CBST.DL stock yet. Tell us why you think CBST.DL will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in CBST.DL.

No players have picked CBST.DL yet. Tell us why you think CBST.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for CBST.DL.